Download PDF
Z Gastroenterol 2001; 39: 38
DOI: 10.1055/s-2001-919031
Supplement

© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New York

Edouard Herriot Experience with the MARS in 5 Patients experiencing Hepatic Failure

B. Delafosse1 , E. Garnier1 , J. Dumortier2 , O. Boillot2
  • 1Intensive care unit and liver transplant unit
  • 2Edouard Herriot hospital, 69 003 Lyon, France
Further Information

Publication History

Publication Date:
07 October 2005 (online)

Also available at
    Permissions and Reprints

Patients

Five adult patients, 4male and 1 female, aged from 49 to 76 years, were treated by MARS. Indications were liver failure secondary: to extended hepatectomy in 2 cases (patients 1 and 5), to acute severe rejection in 2 transplanted patients (patients 2 and 3) and to exacerbation of end-stage liver cirrhosis due to B virus (patient 4).

At the time MARS was started, patient conditions are summarized in table [1].

Table 1 Baseline characteristics of patients treated with MARS Patient HE Prothrombin (%) Total bilirubin Anuria Creatinine 1 IVb 29 493 yes 305 2 I 21 376 yes 192 3 IVa 20 294 yes 143 4 I 14 409 yes 577 5 IVa 9 210 yes 371

Numbers of MARS sessions were 2, 1, 2, 7 and 1 in patients 1,2, 3, 4 and 5 respectively. Total duration of sessions were 16, 8, 25, 87 and 5 hours.